Cargando…
Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience
OBJECTIVES: The Milan system for reporting salivary gland cytopathology (MSRSGC) classification has been proposed to improve reproducibility in the management of salivary gland lesions. Fine-needle aspiration cytology (FNAC) is a widely accepted, well-tolerated, cost-effective, minimally invasive di...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422464/ https://www.ncbi.nlm.nih.gov/pubmed/34512790 http://dx.doi.org/10.25259/Cytojournal_26_2020 |
_version_ | 1783749291604443136 |
---|---|
author | Bharti, Jyotsna Naresh Elhence, Poonam Rao, Meenakshi Nalwa, Aasma Khera, Sudeep |
author_facet | Bharti, Jyotsna Naresh Elhence, Poonam Rao, Meenakshi Nalwa, Aasma Khera, Sudeep |
author_sort | Bharti, Jyotsna Naresh |
collection | PubMed |
description | OBJECTIVES: The Milan system for reporting salivary gland cytopathology (MSRSGC) classification has been proposed to improve reproducibility in the management of salivary gland lesions. Fine-needle aspiration cytology (FNAC) is a widely accepted, well-tolerated, cost-effective, minimally invasive diagnostic method for pre-operative evaluation of salivary gland lesion that aids management decisions. The present study aims to reclassify the salivary gland FNAC aspirates by applying MSRSGC and calculating the risk of neoplasm and malignancy for each diagnostic category. MATERIAL AND METHODS: The present study is a retrospective observational study done for 54 months. A total of 168 cases of salivary gland FNA, 54 cases were excised in our institute for histopathology. Retrospective reviews were performed, and the FNAC cases were reclassified according to the Milan system, and the results of FNAC and final histology were correlated, wherever available. Furthermore, the risk of malignancy was calculated for all the diagnostic categories. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy (DA) of FNAC were determined. RESULTS: In the present study, the age of patients ranged from 3 to 86 years, with a mean age of 39 years. Among all the patients, 61.3% were male, and 38.6% were female. However, only 54 salivary gland FNA samples for which histopathology was available were categorized into six categories. Among them, category IV (neoplastic) had a maximum number of cases of 66.6%. The rate of malignancy was calculated for all diagnostic categories as follows: (1) Non-diagnostic: 0.0%, (2) non-neoplastic 0.0%, (3) atypia of undermined significance 100%, (4a) benign 5.5%, (4b) uncertain malignant potential 33.33%, (5) suspicious for malignancy 00%, and (6) malignancy 80%. The sensitivity, specificity, PPV, NPV, and DA for differentiating between benign and malignant neoplasm were 36.3%, 94.4%, 66.6%, 82.9%, and 80%. Two false-positive and seven false-negative neoplastic cases were noted. CONCLUSION: FNAC is a reliable, minimally invasive diagnostic method with high DA for diagnosing salivary gland lesions. Most salivary gland lesions can be accurately diagnosed on FNAC with adequate sampling and cytopathologists experience. |
format | Online Article Text |
id | pubmed-8422464 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-84224642021-09-09 Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience Bharti, Jyotsna Naresh Elhence, Poonam Rao, Meenakshi Nalwa, Aasma Khera, Sudeep Cytojournal Research Article OBJECTIVES: The Milan system for reporting salivary gland cytopathology (MSRSGC) classification has been proposed to improve reproducibility in the management of salivary gland lesions. Fine-needle aspiration cytology (FNAC) is a widely accepted, well-tolerated, cost-effective, minimally invasive diagnostic method for pre-operative evaluation of salivary gland lesion that aids management decisions. The present study aims to reclassify the salivary gland FNAC aspirates by applying MSRSGC and calculating the risk of neoplasm and malignancy for each diagnostic category. MATERIAL AND METHODS: The present study is a retrospective observational study done for 54 months. A total of 168 cases of salivary gland FNA, 54 cases were excised in our institute for histopathology. Retrospective reviews were performed, and the FNAC cases were reclassified according to the Milan system, and the results of FNAC and final histology were correlated, wherever available. Furthermore, the risk of malignancy was calculated for all the diagnostic categories. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy (DA) of FNAC were determined. RESULTS: In the present study, the age of patients ranged from 3 to 86 years, with a mean age of 39 years. Among all the patients, 61.3% were male, and 38.6% were female. However, only 54 salivary gland FNA samples for which histopathology was available were categorized into six categories. Among them, category IV (neoplastic) had a maximum number of cases of 66.6%. The rate of malignancy was calculated for all diagnostic categories as follows: (1) Non-diagnostic: 0.0%, (2) non-neoplastic 0.0%, (3) atypia of undermined significance 100%, (4a) benign 5.5%, (4b) uncertain malignant potential 33.33%, (5) suspicious for malignancy 00%, and (6) malignancy 80%. The sensitivity, specificity, PPV, NPV, and DA for differentiating between benign and malignant neoplasm were 36.3%, 94.4%, 66.6%, 82.9%, and 80%. Two false-positive and seven false-negative neoplastic cases were noted. CONCLUSION: FNAC is a reliable, minimally invasive diagnostic method with high DA for diagnosing salivary gland lesions. Most salivary gland lesions can be accurately diagnosed on FNAC with adequate sampling and cytopathologists experience. Scientific Scholar 2021-08-02 /pmc/articles/PMC8422464/ /pubmed/34512790 http://dx.doi.org/10.25259/Cytojournal_26_2020 Text en © 2021 Cytopathology Foundation Inc, Published by Scientific Scholar https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Research Article Bharti, Jyotsna Naresh Elhence, Poonam Rao, Meenakshi Nalwa, Aasma Khera, Sudeep Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience |
title | Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience |
title_full | Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience |
title_fullStr | Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience |
title_full_unstemmed | Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience |
title_short | Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience |
title_sort | risk stratification by application of milan system for reporting salivary gland cytopathology: a tertiary care experience |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422464/ https://www.ncbi.nlm.nih.gov/pubmed/34512790 http://dx.doi.org/10.25259/Cytojournal_26_2020 |
work_keys_str_mv | AT bhartijyotsnanaresh riskstratificationbyapplicationofmilansystemforreportingsalivaryglandcytopathologyatertiarycareexperience AT elhencepoonam riskstratificationbyapplicationofmilansystemforreportingsalivaryglandcytopathologyatertiarycareexperience AT raomeenakshi riskstratificationbyapplicationofmilansystemforreportingsalivaryglandcytopathologyatertiarycareexperience AT nalwaaasma riskstratificationbyapplicationofmilansystemforreportingsalivaryglandcytopathologyatertiarycareexperience AT kherasudeep riskstratificationbyapplicationofmilansystemforreportingsalivaryglandcytopathologyatertiarycareexperience |